Neutrophil NETworking in ENL: potential as a putative biomarker: future insights

S Sahu, K Sharma, M Sharma, T Narang… - Frontiers in …, 2021 - frontiersin.org
Erythema nodosum leprosum (ENL), also known as type 2 reaction (T2R) is an immune
complex mediated (type III hypersensitivity) reactional state encountered in patients with …

Th17 cells and cytokines in leprosy: understanding the immune response and polarization

LM Zaniolo, AS Damazo - Revista da Sociedade Brasileira de …, 2023 - SciELO Brasil
While there are conflicting data concerning interleukin (IL)-17 levels in the serum of patients
with leprosy compared with those in healthy controls, higher levels have been more evident …

Diagnostic value of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and platelet-to-lymphocyte ratio in the diagnosis of erythema nodosum leprosum: A …

N Tanojo, Damayanti, B Utomo, E Ervianti… - Tropical Medicine and …, 2022 - mdpi.com
Erythema nodosum leprosum (ENL) is an acute immune complex-mediated condition of the
dermis, subcutaneous tissue, and other tissues seen in patients with multibacillary (MB) …

Apremilast in multibacillary leprosy patients with chronic and recurrent erythema nodosum leprosum: a prospective single‐centre pilot study.

T Narang, R Ashraf, A Kaushik… - Journal of the …, 2021 - search.ebscohost.com
There is clearance of lesions with minimal postinflammatory hyperpigmentation at one
month of treatment with apremilast and prednisolone (df). gl 1 TableResponse to treatment …

Association between asthma, rhinitis and atopic dermatitis with leprosy: A case-control study

MDL Tenório, JMS Araujo, EV de Melo… - Indian Journal of …, 2023 - ijdvl.com
Background Considering the cross-regulation of Th1 and Th2 responses, we hypothesised
that atopic diseases (Th2) inhibit the protective Th1 immune response to Mycobacterium …

Effective management of severe chronic erythema nodosum leprosum in adolescent patient using ustekinumab and apremilast: A case report

L Mengeot, M Jachiet, E Bourrat… - Journal of the …, 2024 - pubmed.ncbi.nlm.nih.gov
Effective management of severe chronic erythema nodosum leprosum in adolescent patient
using ustekinumab and apremilast: A case report Effective management of severe chronic …

[HTML][HTML] Analysis of interleukin 7 and platelet-derived growth factor-BB mRNA expression as potential markers in erythema nodosum leprosum

FK Bandjar, F Tabri, SV Muchtar, M Hatta… - Dermatology …, 2024 - ncbi.nlm.nih.gov
Erythema nodosum leprosum (ENL) is an immunological complication of leprosy
characterized by acute inflammation of the skin, nerves, and other organs. Identifying …

Effect of Curcuma longa Extract as Adjuvant Therapy on IL-6 Serum Levels in Leprosy Type 1 Reaction Patients

SN Putri, FEP Mundhofir, R Yuniati… - Jurnal Health …, 2024 - jurnal.healthsains.co.id
Type 1 leprosy reaction/Reversal reaction (RR) is an inflammatory episode in existing
leprosy lesions and aggravates the pain rate. Long-term therapy with steroids causes a …

Diagnostic Value of Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio, and Platelet-to-Lymphocyte Ratio in the Diagnosis of Erythema Nodosum …

N Natalia Tanojo, D Damayanti… - Tropical Medicine and … - repository.unair.ac.id
Erythema nodosum leprosum (ENL) is an acute immune complex-mediated condition of the
dermis, subcutaneous tissue, and other tissues seen in patients with multibacillary (MB) …

Differential expression of interleukin-6 in leprosy reactions

M Sharma, P Singh - Indian Journal of Dermatology, Venereology and …, 2022 - ijdvl.com
Sir, We read with interest the publication of Moreno et al. 1, where interleukin-6 levels in
serum of leprosy patients with erythema nodosum leprosum were compared with the …